Related Experiment Videos
Patterns of Kawasaki syndrome presentation
Insights
Kawasaki syndrome (KS) can cause coronary artery issues in children. Early diagnosis and treatment with gamma globulin are crucial to prevent these serious complications.
Area of Science:
- Pediatrics
- Infectious Diseases
- Cardiology
Background:
- Kawasaki syndrome (KS) is a systemic inflammatory disease of unknown cause.
- It can lead to coronary artery aneurysms and thrombosis in children.
- Diagnosis relies on clinical guidelines, but atypical presentations can cause delays.
Purpose of the Study:
- To illustrate the varied presentations of Kawasaki syndrome.
- To highlight the importance of considering KS even with unusual symptoms.
- To emphasize timely diagnosis and treatment.
Main Methods:
- Review of patient cases with Kawasaki syndrome.
- Analysis of clinical presentations and diagnostic challenges.
- Comparison with established diagnostic criteria.
Main Results:
- Kawasaki syndrome presents with diverse symptoms, some overlapping with otolaryngologic conditions.
- Delayed diagnosis can occur when symptoms deviate from standard criteria.
- Intravenous gamma globulin administered within 10 days reduces coronary artery abnormalities.
Conclusions:
- Recognizing the varied clinical patterns of KS is essential for prompt diagnosis.
- Early intervention with gamma globulin is critical for preventing cardiac sequelae.
- Increased awareness among clinicians can improve patient outcomes.
Abstract:
Kawasaki syndrome (KS) is a systemic disorder of unknown etiology that can lead to coronary artery aneurysm and thrombosis in a significant number of children. It is defined by a number of clinical guidelines set by the Centers for Disease Control (Rauch, A.M., Hurwitz, E.S. (1985) Centers for Disease Control (CDC). Case Definition for Kawasaki syndrome. Pediatr. Infect. Dis. 4, 702-703). Many of the symptoms of this illness may lead the patient to the otolaryngologist. These criteria include injected or fissured lips, injected pharynx, strawberry tongue and cervical lymphadenopathy. When administered in the first 10 days of the illness, gamma globulin has been demonstrated to reduce the prevalence of coronary artery abnormalities (Newburger, J.W., Takahashi, M., Burns, J.C. et al. (1986) Treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 315, 341-347). Unfortunately, when a diagnosis of KS is not considered or if a patient presents with unusual symptoms that are not consistent with the CDC guidelines, the diagnosis and treatment of KS can be delayed or even missed. We present a series of patients with KS to illustrate its patterns of presentation.